Management of Metabolic Alkalosis

Initial Assessment and Classification

The American College of Cardiology recommends measuring urinary chloride concentration to distinguish chloride-responsive from chloride-resistant alkalosis, as this guides the entire treatment strategy 1, 2
The European Society of Cardiology suggests that chloride-responsive alkalosis typically results from volume contraction, vomiting, or diuretic use, while chloride-resistant alkalosis suggests mineralocorticoid excess, Bartter syndrome, or Gitelman syndrome 1
Checking serum electrolytes, including sodium, potassium, chloride, and bicarbonate, along with arterial blood gas to assess pH and the degree of compensatory hypoventilation is crucial 2

The American Heart Association recommends discontinuing or reducing diuretic therapy immediately, as loop and thiazide diuretics are the most common cause of metabolic alkalosis 1, 2
Administering normal saline (0.9% NaCl) to reverse volume contraction and provide the chloride necessary for bicarbonate excretion is essential 2
In the absence of cardiac compromise, isotonic saline can be infused at 15-20 ml/kg/h initially, with subsequent fluid choice depending on corrected serum sodium 3
Potassium chloride supplementation is absolutely essential, with doses of 20-60 mEq/day frequently required to maintain serum potassium in the 4.5-5.0 mEq/L range 1, 2

Amiloride is the most effective potassium-sparing diuretic for metabolic alkalosis, starting at 2.5 mg daily and titrating up to 5 mg daily 1, 2
Spironolactone (25-100 mg daily) is an alternative, especially in heart failure patients 1, 2
Acetazolamide 500 mg IV as a single dose can cause a rapid fall in serum bicarbonate with normalization of pH in patients with heart failure and adequate kidney function 1

In patients with Bartter or Gitelman syndrome, treatment requires sodium chloride supplementation (5-10 mmol/kg/day) plus potassium chloride 1
NSAIDs (indomethacin or ibuprofen) can reduce prostaglandin-mediated salt wasting in symptomatic patients with Bartter or Gitelman syndrome 1
Appropriate management of circulatory failure is integral in heart failure patients, and adding an aldosterone antagonist (spironolactone) to the diuretic regimen is recommended 1, 2

Serial electrolytes (sodium, potassium, chloride, bicarbonate) should be monitored 2
Arterial blood gas should be assessed to evaluate pH and compensatory response 2
Urine chloride should be monitored to confirm appropriate classification 2
Volume status should be evaluated through clinical examination and urine output 2

Sodium bicarbonate or any alkalinizing agents should never be administered, as they are absolutely contraindicated and will worsen the alkalosis 1, 2
Furosemide should not be used unless hypervolemia, hyperkalemia, or renal acidosis are present, as loop diuretics perpetuate the alkalosis 1
Non-chloride containing potassium supplements (citrate, gluconate) should be avoided, as they perpetuate alkalosis 2